miR-508-5p regulates multidrug resistance of gastric cancer by targeting ABCB1 and ZNRD1. (Q39119238)

9 September 2017

miR-508-5p regulates multidrug resistance of gastric cancer by targeting ABCB1 and ZNRD1. (English)

1 reference

9 September 2017

multiple drug resistance

1 reference

Y Shang

1

1 reference

9 September 2017

Z Zhang

2

1 reference

9 September 2017

Z Liu

3

1 reference

9 September 2017

B Feng

4

1 reference

9 September 2017

G Ren

5

1 reference

9 September 2017

K Li

6

1 reference

9 September 2017

L Zhou

7

1 reference

9 September 2017

Y Sun

8

1 reference

9 September 2017

M Li

9

1 reference

9 September 2017

J Zhou

10

1 reference

9 September 2017

Y An

11

1 reference

9 September 2017

K Wu

12

1 reference

9 September 2017

Y Nie

13

1 reference

9 September 2017

D Fan

14

1 reference

9 September 2017

language of work or name

English

0 references

publication date

29 July 2013

1 reference

9 September 2017

1 reference

9 September 2017

33

1 reference

9 September 2017

3267-3276

1 reference

9 September 2017

25

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2013.297

9 September 2017

0 references

cites work

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.297

Mechanism of cell adaptation: when and how do cancer cells develop chemoresistance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.297

Molecular mechanisms of cisplatin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.297

Reversal of P-gp and MRP1-mediated multidrug resistance by H6, a gypenoside aglycon from Gynostemma pentaphyllum, in vincristine-resistant human oral cancer (KB/VCR) cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.297

Overexpression of lung resistance-related protein and P-glycoprotein and response to induction chemotherapy in acute myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.297

Death receptor 5 and Bcl-2 protein expression as predictors of tumor response to gemcitabine and cisplatin in patients with advanced non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.297

Bcl-2 blocks cisplatin-induced apoptosis and predicts poor outcome following chemoradiation treatment in advanced oropharyngeal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.297

Expression of Bcl-xL in ovarian carcinoma is associated with chemoresistance and recurrent disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.297

p53 in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.297

Upregulation of ZNRD1 enhances cisplatin resistance in human esophageal cancer cells by regulation of ERCC1 and Bcl-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.297

ZNRD1 mediates resistance of gastric cancer cells to methotrexate by regulation of IMPDH2 and Bcl-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.297

Identification of GAS1 as an epirubicin resistance-related gene in human gastric cancer cells with a partially randomized small interfering RNA library

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.297

Ribosomal proteins S13 and L23 promote multidrug resistance in gastric cancer cells by suppressing drug-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.297

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.297

Reduced miR-128 in breast tumor-initiating cells induces chemotherapeutic resistance via Bmi-1 and ABCC5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.297

MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.297

MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.297

DNA methylation-regulated miR-193a-3p dictates resistance of hepatocellular carcinoma to 5-fluorouracil via repression of SRSF2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.297

Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.297

Down-regulation of miR-27a might inhibit proliferation and drug resistance of gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.297

miR-497 modulates multidrug resistance of human cancer cell lines by targeting BCL2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.297

miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.297

miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.297

miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.297

Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.297

Down-regulated miR-331-5p and miR-27a are associated with chemotherapy resistance and relapse in leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.297

Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.297

Down-regulation of miR-27a might reverse multidrug resistance of esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.297

Tunicamycin depresses P-glycoprotein glycosylation without an effect on its membrane localization and drug efflux activity in L1210 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.297

Functional characterization of glycosylation-deficient human P-glycoprotein using a vaccinia virus expression system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.297

Inhibition of N-linked glycosylation of P-glycoprotein by tunicamycin results in a reduced multidrug resistance phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.297

Reversal of multidrug resistance of gastric cancer cells by down-regulation of ZNRD1 with ZNRD1 siRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.297

Overexpression of ZNRD1 promotes multidrug-resistant phenotype of gastric cancer cells through upregulation of P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.297

Identification of microRNA-21 as a biomarker for chemoresistance and clinical outcome following adjuvant therapy in resectable pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.297

MicroRNA-10b is a prognostic indicator in colorectal cancer and confers resistance to the chemotherapeutic agent 5-fluorouracil in colorectal cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.297

miRNA signature associated with outcome of gastric cancer patients following chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.297

MicroRNAs in the p53 network: micromanagement of tumour suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.297

Embryonic stem cell-specific microRNAs regulate the G1-S transition and promote rapid proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.297

Dynamic cytotoxic response to microcystins using microelectronic sensor arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.297

P-glycoprotein and cytochrome P450 3A act together in restricting the oral bioavailability of paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.297

MicroRNAs as oncogenes and tumor suppressors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.297

15-lipoxygenase-1 activates tumor suppressor p53 independent of enzymatic activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.297

Tumor microRNA expression patterns associated with resistance to platinum based chemotherapy and survival in ovarian cancer patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.297

Identification of miRNomes in Human Liver and Hepatocellular Carcinoma Reveals miR-199a/b-3p as Therapeutic Target for Hepatocellular Carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.297

31 March 2020

Identifiers

DOI

10.1038/ONC.2013.297

1 reference

9 September 2017

1 reference